# Calyx Chemicals & Pharmaceuticals Limited – FDA Inspection, May 17, 2024

Source: https://www.keypedia.com/records/fda_inspections/calyx-chemicals-pharmaceuticals-limited/0e4db988-4bbb-42d5-a17d-9901226c1dca
Source feed: FDA_Inspections

> FDA inspection 1240456 of Calyx Chemicals & Pharmaceuticals Limited, May 17, 2024. Classification: Official Action Indicated (OAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1240456
- Company Name: Calyx Chemicals & Pharmaceuticals Limited
- Inspection Date: 2024-05-17
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1110153 - 2019-11-08
- [FDA Inspection 967429 - 2016-03-04](https://www.keypedia.com/records/fda_inspections/calyx-chemicals-pharmaceuticals-limited/f179bf14-ab8e-4879-a384-b878e09ae5c0)
- FDA Inspection 775620 - 2012-03-27
- FDA Inspection 641001 - 2009-09-18

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/guerlain-ulysse/aeef6f71-43b1-4116-b563-8bb3f2966d6a)
- [Yvins Dezan](https://www.keypedia.com/people/yvins-dezan/e9fd12e6-c090-4eb6-bc78-8b80e8a90946)

Company: https://www.keypedia.com/companies/calyx-chemicals-pharmaceuticals-limited/e01c292e-7fb4-4afa-b74e-c1afc698d94d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
